Validation of Acromegaly Quality of Life Questionnaire (AcroQoL) for the Iranian population

被引:1
|
作者
Danaei, Mina [1 ]
Bahadorizadeh, Leyla [2 ]
Dehnad, Afsaneh [3 ]
Mohamadzadeh, Shirin [4 ]
Hashemi-Madani, Nahid [5 ]
Khamseh, Mohammad E. [5 ]
机构
[1] Kerman Univ Med Sci, Social Determinants Hlth Res Ctr, Inst Futures Studies Hlth, Kerman, Iran
[2] Iran Univ Med Sci, Antimicrobial Resistance Res Ctr, Inst Immunol & Infect Dis, Tehran, Iran
[3] Iran Univ Med Sci, Sch Hlth Management & Informat Sci, Tehran, Iran
[4] Alzahra Univ, Dept English Language, Tehran, Iran
[5] Iran Univ Med Sci IUMS, Endocrine Res Ctr, Inst Endocrinol & Metab, Firouzeh St,Vali Asr Ave,POB 1593748711, Tehran, Iran
关键词
Acromegaly; Quality of life; Disease-specific questionnaire; CONTENT VALIDITY; CONSENSUS;
D O I
10.1186/s40359-022-00781-0
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Background Acromegaly is a chronic disease significantly affects the physical, emotional, and health-related aspects of patients' life. This study aimed to validate the Acromegaly Quality of Life Questionnaire (AcroQoL) for the Persian-speaking population. Methods This cross-sectional study recruited 73 Iranian patients with a confirmed diagnosis of acromegaly. The content validity of the scales was evaluated by an expert panel of eight endocrinologists applying content validity index (CVI) and content validity ratio (CVR). Construct validity was assessed by using confirmatory factor analysis. Internal consistency was assessed on the basis of Cronbach's alpha, and a goodness-of-fit (GoF) index was calculated to display whether the model fitted the data. Results CVI and CVR yielded values of 0.85 and 0.80, respectively (Acceptable CVI: > 0.78 and CVR: > 0.75). The average variances extracted (AVE) from physical and psychological dimensions were 0.520 and 0.462, respectively, exceeding the minimum criterion of 0.40. Cronbach's alpha for physical and psychological dimensions equaled 0.868 and 0.866, respectively, indicating the adequate internal consistency of multiple items for each construct. The subscales' R square and path coefficient were greater than the recommended threshold as 0.75 (physical dimension: 0.778, psychological dimension: 0.873), demonstrating the suitability of this criterion. Finally, the GoF value of 0.29 indicated the model's moderate fit. Conclusions The findings revealed that the Persian version of AcroQoL is of adequate validity and reliability for evaluating the quality of life of Iranian people with acromegaly.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Validation of Acromegaly Quality of Life Questionnaire (AcroQoL) for the Iranian population
    Mina Danaei
    Leyla Bahadorizadeh
    Afsaneh Dehnad
    Shirin Mohamadzadeh
    Nahid Hashemi-Madani
    Mohammad E. Khamseh
    BMC Psychology, 10
  • [2] Acromegaly quality of life questionnaire (AcroQoL)
    Badia X.
    Webb S.M.
    Prieto L.
    Lara N.
    Health and Quality of Life Outcomes, 2 (1)
  • [3] Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL)
    Trepp, R
    Everts, R
    Stettler, C
    Fischli, S
    Allemann, S
    Webb, SM
    Christ, ER
    CLINICAL ENDOCRINOLOGY, 2005, 63 (01) : 103 - 110
  • [4] Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire
    Vandeva, Silvia
    Yaneva, Maria
    Natchev, Emil
    Elenkova, Atanaska
    Kalinov, Krasimir
    Zacharieva, Sabina
    ENDOCRINE, 2015, 49 (03) : 774 - 782
  • [5] Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly:: development and psychometric properties
    Webb, SM
    Prieto, L
    Badia, X
    Albareda, M
    Catalá, M
    Gaztambide, S
    Lucas, T
    Páramo, C
    Picó, A
    Lucas, A
    Halperin, I
    Obiols, G
    Astorga, R
    CLINICAL ENDOCRINOLOGY, 2002, 57 (02) : 251 - 258
  • [6] Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire
    Silvia Vandeva
    Maria Yaneva
    Emil Natchev
    Atanaska Elenkova
    Krasimir Kalinov
    Sabina Zacharieva
    Endocrine, 2015, 49 : 774 - 782
  • [7] Treatment of acromegaly improves quality of life, measured by AcroQol
    Paisley, Angela N.
    Rowles, Susannah V.
    Roberts, Margaret E.
    Webb, Susan M.
    Prieto, Badia L.
    Shalet, Stephen M.
    Trainer, Peter J.
    CLINICAL ENDOCRINOLOGY, 2007, 67 (03) : 358 - 362
  • [8] Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study
    Webb, Susan M.
    Badia, Xavier
    Surinach, Nuria Lara
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 155 (02) : 269 - 277
  • [9] Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the acromegaly quality of life questionnaire (AcroQol) (vol 63, pg 103, 2005)
    Trepp, R
    Everts, R
    Stettler, C
    Fischli, S
    Allemann, S
    Webb, SM
    Christ, ER
    CLINICAL ENDOCRINOLOGY, 2005, 63 (02) : 238 - 238
  • [10] Treatment of acromegaly is associated with improved quality of life (QOL), measured with AcroQol
    Paisley, A
    Trainer, P
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152